Lynch syndrome-associated breast cancers: Clinicopathologic characteristics of a case series from the colon cancer family registry

Clinical Cancer Research

Volumn 16, Issue 7, 2010, Pages 2214-2224

  Walsh, Michael D ^a,b   Buchanan, Daniel D ^a,b   Cummings, Margaret C ^c   Pearson, Sally Ann ^a   Arnold, Sven T ^a   Clendenning, Mark ^a   Walters, Rhiannon ^a   McKeone, Diane M ^a   Spurdle, Amanda B ^a   Hopper, John L ^f   Jenkins, Mark A ^f   Phillips, Kerry D ^h   Suthers, Graeme K ^h,i   George, Jill ^j   Goldblatt, Jack ^j,k   Muir, Amanda ^l   Tucker, Kathy ^l   Pelzer, Elise ^d   Gattas, Michael R ^d   Woodall, Sonja ^m   Parry, Susan ^m,n   Macrae, Finlay A ^g   Haile, Robert W ^o   Baron, John A ^p   Potter, John D ^q   Le Marchand, Loic ^r   Bapat, Bharati ^s   Thibodeau, Stephen N ^t   Lindor, Noralane M ^t   McGuckin, Michael A ^e   Young, Joanne P ^a,b   more..

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^e MATER MEDICAL RESEARCH INSTITUTE   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g ROYAL MELBOURNE HOSPITAL   (Australia)

^h South Australian Clinical Genetics Service   (Australia)

ⁱ UNIVERSITY OF ADELAIDE   (Australia)

^j KING EDWARD MEMORIAL HOSPITAL   (Australia)

^k UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^l PRINCE OF WALES HOSPITAL   (Australia)

^m AUCKLAND CITY HOSPITAL   (New Zealand)

ⁿ UNIVERSITY OF AUCKLAND   (New Zealand)

^o UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^p DARTMOUTH MEDICAL SCHOOL   (United States)

^q Fred Hutchinson Cancer Research Center   (United States)

^r UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^s MOUNT SINAI HOSPITAL   (Canada)

^t MAYO CLINIC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; MISMATCH REPAIR PROTEIN; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER REGISTRY; COLON CANCER; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILIAL CANCER; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MITOSIS INDEX; NUCLEOTIDE SEQUENCE; ONSET AGE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CARCINOMA; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MISMATCH REPAIR; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE DETECTION; HUMANS; MALE; MIDDLE AGED; MUTATION; REGISTRIES;

EID: 77950655236     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-09-3058     Document Type: Article

References (48)

1. Anonymous . Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 2001;358:1389-1399
2. Claus EB, Schildkraut JM, Thompson WD, Risch NJ. The genetic attributable risk of breast and ovarian cancer. Cancer 1996;77:2318-2324
3. Foulkes WD. Inherited susceptibility to common cancers. N Engl J Med 2008;359:2143-2153
4. Tan DS, Marchio C, Reis-Filho JS. Hereditary breast cancer: from molecular pathology to tailored therapies. J Clin Pathol 2008;61:1073-1082
5. Claus EB, Risch NJ, Thompson WD. Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol 1990;131:961-972
6. Jass JR. Hereditary non-polyposis colorectal cancer: the rise and fall of a confusing term. World J Gastroenterol 2006;12:4943-4950
7. Woods MO, Williams P, Careen A, et al. A new variant database for mismatch repair genes associated with Lynch syndrome. Hum Mutat 2007;28:669-673
8. Müller A, Edmonston TB, Corao DA, et al. Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer. Cancer Res 2002;62:1014-1019
9. Vasen HF, Morreau H, Nortier JW. Is breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer? Am J Hum Genet 2001;68:1533-1535
10. de Leeuw WJ, van Puijenbroek M, Tollenaar RA, Cornelisse CJ, Vasen HF, Morreau H. Correspondence re: A. Müller et al., Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer. Cancer Res, 62:1014-1019, 2002. Cancer Res 2003;63:1148-1149
11. Scott RJ, McPhillips M, Meldrum CJ, et al. Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. Am J Hum Genet 2001;68:118-127
12. Oliveira Ferreira F, Napoli Ferreira CC, Rossi BM, et al. Frequency of extra-colonic tumors in hereditary nonpolyposis colorectal cancer (HNPCC) and familial colorectal cancer (FCC) Brazilian families: an analysis by a Brazilian Hereditary Colorectal Cancer Institutional Registry. Fam Cancer 2004;3:41-47
13. Shanley S, Fung C, Milliken J, et al. Breast cancer immunohistochemistry can be useful in triage of some HNPCC families. Fam Cancer 2009;8:251-255
14. Westenend PJ, Schutte R, Hoogmans MM, Wagner A, Dinjens WN. Breast cancer in an MSH2 gene mutation carrier. Hum Pathol 2005;36:1322-1326
15. Barrow E, Robinson L, Alduaij W, et al. Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations. Clin Genet 2009;75:141-149
16. Geary J, Sasieni P, Houlston R, et al. Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC). Fam Cancer 2008;7:163-172
17. Lindor NM, Burgart LJ, Leontovich O, et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 2002;20:1043-1048
18. Bergthorsson JT, Egilsson V, Gudmundsson J, Arason A, Ingvarsson S. Identification of a breast tumor with microsatellite instability in a potential carrier of the hereditary non-polyposis colon cancer trait. Clin Genet 1995;47:305-310
19. Boyd J, Rhei E, Federici MG, et al. Male breast cancer in the hereditary nonpolyposis colorectal cancer syndrome. Breast Cancer Res Treat 1999;53:87-91.
20. Caluseriu O, Cordisco EL, Viel A, et al. Four novel MSH2 and MLH1 frameshift mutations and occurrence of a breast cancer phenocopy in hereditary nonpolyposis colorectal cancer. Hum Mutat 2001;17:521-525
21. Risinger JI, Barrett JC, Watson P, Lynch HT, Boyd J. Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome. Cancer 1996;77:1836-1843
22. Siah SP, Quinn DM, Bennett GD, et al. Microsatellite instability markers in breast cancer: a review and study showing MSI was not detected at 'BAT 25' and 'BAT 26' microsatellite markers in early-onset breast cancer. Breast Cancer Res Treat 2000;60:135-142
23. Spagnoletti I, Pizzi C, Galietta A, et al. Loss of hMSH2 expression in primary breast cancer with p53 alterations. Oncol Rep 2004;11:845-851
24. Newcomb PA, Baron J, Cotterchio M, et al. Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev 2007;16:2331-3243
25. Elston CW. The assessment of histological differentiation in breast cancer. Aust N Z J Surg 1984;54:11-15
26. Walsh MD, Cummings MC, Buchanan DD, et al. Molecular, pathologic, and clinical features of early-onset endometrial cancer: identifying presumptive Lynch syndrome patients. Clin Cancer Res 2008;14:1692-1700
27. Poynter JN, Siegmund KD, Weisenberger DJ, et al. Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening. Cancer Epidemiol Biomarkers Prev 2008;17:3208-3215
28. Lakhani SR, Jacquemier J, Sloane JP, et al. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst 1998;90:1138-1145
29. Jönsson M, Johannsson O, Borg Å. Infrequent occurrence of microsatellite instability in sporadic and familial breast cancer. Eur J Cancer 1995;31A:2330-2334
30. Lee SC, Berg KD, Sherman ME, Griffin CA, Eshleman JR. Microsatellite instability is infrequent in medullary breast cancer. Am J Clin Pathol 2001;115:823-827
31. Özer E, Yuksel E, Kizildag S, et al. Microsatellite instability in early-onset breast cancer. Pathol Res Pract 2002;198:525-530
32. Zhou XP, Hoang JM, Li YJ, et al. Determination of the replication error phenotype in human tumors without the requirement for matching normal DNA by analysis of mononucleotide repeat microsatellites. Genes Chromosomes Cancer 1998;21:101-107
33. Walsh T, Chappell SA, Shaw JA, Walker RA. Microsatellite instability in ductal carcinoma in situ of the breast. J Pathol 1998;185:18-24.
34. Jeon HM, Lynch PM, Howard L, Ajani J, Levin B, Frazier ML. Mutation of the hMSH2 gene in two families with hereditary nonpolyposis colorectal cancer. Hum Mutat 1996;7:327-333
35. Jensen UB, Sunde L, Timshel S, et al. Mismatch repair defective breast cancer in the hereditary nonpolyposis colorectal cancer syndrome. Breast Cancer Res Treat 2009; Jul 3 [Epub ahead of print].
36. Stupart DA, Goldberg PA, Algar U, Ramesar R. Cancer risk in a cohort of subjects carrying a single mismatch repair gene mutation. Fam Cancer 2009;8:519-523
37. Schmitt FC, Soares R, Gobbi H, et al. Microsatellite instability in medullary breast carcinomas. Int J Cancer 1999;82:644-647
38. González-Aguilera JJ, Nejda N, Fernández FJ, et al. Genetic alterations and MSI status in primary, synchronous, and metachronous tumors in a family with hereditary nonpolyposis colorectal cancer (HNPCC). Am J Clin Oncol 2003;26:386-391
39. Müller A, Beyser K, Arps H, Bolander S, Becker H, Rüschhoff J. Genotype and phenotype of a new 2-bp deletion of hMSH2 at codon 233. Virchows Arch 2001;439:191-195
40. Yee CJ, Roodi N, Verrier CS, Parl FF. Microsatellite instability and loss of heterozygosity in breast cancer. Cancer Res 1994;54:1641-1644
41. Cederquist K, Emanuelsson M, Wiklund F, Golovleva I, Palmqvist R, Grönberg H. Two Swedish founder MSH6 mutations, one nonsense and one missense, conferring high cumulative risk of Lynch syndrome. Clin Genet 2005;68:533-541
42. Jenkins MA, Hayashi S, O'Shea AM, et al. Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study. Gastroenterology 2007;133:48-56.
43. Young J, Simms LA, Biden KG, et al. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis. Am J Pathol 2001;159:2107-2116
44. Plaschke J, Kruppa C, Tischler R, et al. Sequence analysis of the mismatch repair gene hMSH6 in the germline of patients with familial and sporadic colorectal cancer. Int J Cancer 2000;85:606-613
45. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 1994;343:692-695
46. Cannon-Albright LA, Thomas A, Goldgar DE, et al. Familiality of cancer in Utah. Cancer Res 1994;54:2378-2385
47. Hemminki K, Vaittinen P. Familial risks in in situ cancers from the Family-Cancer Database. Cancer Epidemiol Biomarkers Prev 1998;7:865-868
48. Dong C, Hemminki K. Second primary neoplasms in 633,964 cancer patients in Sweden, 1958-1996. Int J Cancer 2001;93:155-161